Suppr超能文献

种族因素在夏威夷华法林的用药剂量中起作用吗?

Does ethnicity play a role in the dosing of warfarin in Hawai'i?

作者信息

Tatsuno Sydney Y, Tatsuno Eric M

机构信息

Department of Medicine, John A. Burns School of Medicine, Honolulu, HI.

出版信息

Hawaii J Med Public Health. 2014 Mar;73(3):76-9.

Abstract

Warfarin is the most common anticoagulant prescribed and its metabolism has been linked to two specific genes, CYP2C9 and VKORC1. This study analyzed 113 patients from 4 different ethnic backgrounds (Asian, Native Hawaiian, Portuguese, and Caucasian) and investigated the association between the mean daily dose of warfarin and ethnicity. Caucasian patients required the highest mean daily dose of warfarin 4.4 mg/day while Asian patients required the lowest mean daily dose of warfarin 2.5 mg/day. Portuguese patients and Native Hawaiian patients required mean of 3.8 mg/day. All three groups required a significantly lower dose than Caucasians. When adjusted for weight in kilograms, Native Hawaiian patients required a dose of 4.3 × 10(-2) mg/kg, Portuguese 4.4 × 10(-2) mg/kg and Asians 4.0 × 10(-2) mg/kg. These three populations had similar mean milligrams/kilogram dose requirements while Caucasians required a significantly higher dose of 5.3 × 10(-2) mg/kg. This data suggests that ethnicity should be taken into consideration when dosing warfarin.

摘要

华法林是最常用的处方抗凝剂,其代谢与两个特定基因CYP2C9和VKORC1有关。本研究分析了来自4种不同种族背景(亚洲人、夏威夷原住民、葡萄牙人和白种人)的113名患者,并调查了华法林平均日剂量与种族之间的关联。白种人患者所需华法林的平均日剂量最高,为4.4毫克/天,而亚洲患者所需华法林的平均日剂量最低,为2.5毫克/天。葡萄牙患者和夏威夷原住民患者所需平均剂量为3.8毫克/天。这三组患者所需剂量均显著低于白种人。按千克体重调整后,夏威夷原住民患者所需剂量为4.3×10⁻²毫克/千克,葡萄牙人为4.4×10⁻²毫克/千克,亚洲人为4.0×10⁻²毫克/千克。这三个人群每千克体重的平均毫克剂量需求相似,而白种人所需剂量显著更高,为5.3×10⁻²毫克/千克。该数据表明,在使用华法林给药时应考虑种族因素。

相似文献

1
Does ethnicity play a role in the dosing of warfarin in Hawai'i?
Hawaii J Med Public Health. 2014 Mar;73(3):76-9.
2
Pharmacogenetics of Warfarin in a Diverse Patient Population.
J Cardiovasc Pharmacol Ther. 2019 Nov;24(6):521-533. doi: 10.1177/1074248419843530. Epub 2019 May 7.
5
The pharmacogenetics of the response to warfarin in Chinese.
Br J Clin Pharmacol. 2012 Mar;73(3):340-7. doi: 10.1111/j.1365-2125.2011.04097.x.
7
Prediction of the impact of and genotypes on warfarin-sorafenib interactions in whites and Asians.
Pharmacogenomics. 2020 Aug;21(12):853-862. doi: 10.2217/pgs-2020-0036. Epub 2020 Jul 23.
10
Contribution of VKORC1 and CYP2C9 polymorphisms in the interethnic variability of warfarin dose in Malaysian populations.
Ann Hematol. 2011 Jun;90(6):635-41. doi: 10.1007/s00277-010-1119-6. Epub 2010 Nov 26.

引用本文的文献

1
The Molecular-Social-Genetic Determinants of Cardiovascular Health in Pacific Islanders.
JACC Asia. 2024 Jun 18;4(7):559-565. doi: 10.1016/j.jacasi.2024.04.012. eCollection 2024 Jul.
2
COVID-19 Severity and Thrombo-Inflammatory Response Linked to Ethnicity.
Biomedicines. 2022 Oct 12;10(10):2549. doi: 10.3390/biomedicines10102549.
3
Genotype-Guided Dosing of Warfarin in Chinese Adults: A Multicenter Randomized Clinical Trial.
Circ Genom Precis Med. 2020 Aug;13(4):e002602. doi: 10.1161/CIRCGEN.119.002602. Epub 2020 Jun 8.

本文引用的文献

1
Influence of warfarin dose-associated genotypes on the risk of hemorrhagic complications in Chinese patients on warfarin.
Int J Hematol. 2012 Dec;96(6):719-28. doi: 10.1007/s12185-012-1205-8. Epub 2012 Oct 27.
2
A new warfarin dosing algorithm including VKORC1 3730 G > A polymorphism: comparison with results obtained by other published algorithms.
Eur J Clin Pharmacol. 2012 Aug;68(8):1167-74. doi: 10.1007/s00228-012-1226-5. Epub 2012 Feb 19.
3
Prediction of warfarin dose reductions in Puerto Rican patients, based on combinatorial CYP2C9 and VKORC1 genotypes.
Ann Pharmacother. 2012 Feb;46(2):208-18. doi: 10.1345/aph.1Q190. Epub 2012 Jan 24.
4
Association of the GGCX (CAA)16/17 repeat polymorphism with higher warfarin dose requirements in African Americans.
Pharmacogenet Genomics. 2012 Feb;22(2):152-8. doi: 10.1097/FPC.0b013e32834f288f.
6
The pharmacogenetics of the response to warfarin in Chinese.
Br J Clin Pharmacol. 2012 Mar;73(3):340-7. doi: 10.1111/j.1365-2125.2011.04097.x.
7
Effects of CYP4F2 and GGCX genetic variants on maintenance warfarin dose in a multi-ethnic Asian population.
Thromb Haemost. 2011 Jun;105(6):1100-2. doi: 10.1160/TH11-01-0018. Epub 2011 Apr 7.
9
Proposal of pharmacogenetics-based warfarin dosing algorithm in Korean patients.
J Hum Genet. 2011 Apr;56(4):290-5. doi: 10.1038/jhg.2011.4. Epub 2011 Feb 17.
10
Contribution of VKORC1 and CYP2C9 polymorphisms in the interethnic variability of warfarin dose in Malaysian populations.
Ann Hematol. 2011 Jun;90(6):635-41. doi: 10.1007/s00277-010-1119-6. Epub 2010 Nov 26.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验